0000950170-24-028811.txt : 20240308 0000950170-24-028811.hdr.sgml : 20240308 20240308174040 ACCESSION NUMBER: 0000950170-24-028811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stout Stephen CENTRAL INDEX KEY: 0001970664 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 24735853 MAIL ADDRESS: STREET 1: C/O SHATTUCK LABS, INC. STREET 2: 500 W. 5TH STREET, SUITE 1200 CITY: AUSTIN STATE: TX ZIP: 78701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 ownership.xml 4 X0508 4 2024-03-06 0001680367 Shattuck Labs, Inc. STTK 0001970664 Stout Stephen C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 false true false false See Remarks true Common Stock 2024-03-06 4 M false 4650 3.51 A 83982 D Common Stock 2024-03-06 4 S false 4650 10.53 D 79332 D Common Stock 2024-03-06 4 M false 6459 3.57 A 85791 D Common Stock 2024-03-06 4 S false 6459 10.53 D 79332 D Common Stock 2024-03-06 4 S false 4895 10.53 D 74437 D Stock Option (Right to Buy) 3.51 2024-03-06 4 M false 4650 0.00 D 2032-09-08 Common Stock 4650 9300 D Stock Option (Right to Buy) 3.57 2024-03-06 4 M false 6459 0.00 D 2033-01-25 Common Stock 6459 17391 D Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023. The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024. The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027. General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer /s/ Stephen Stout 2024-03-08